Abacus Planning Group’s Ginkgo Bioworks DNA Stock Holding History

Abacus Planning Group’s Portfolio DNA Stock Details DNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-603	Closed	-$8.06K	–	219
2024 Q2	$8.06K	Hold	603	–	–	﹤0.01%	218
2024 Q1	$28K	Hold	603	–	–	0.01%	206
2023 Q4	$40.8K	Hold	603	–	–	0.01%	199
2023 Q3	$43.6K	Hold	603	–	–	0.01%	187
2023 Q2	$44.9K	Hold	603	–	–	0.01%	196
2023 Q1	$32.1K	Hold	603	–	–	0.01%	190
2022 Q4	$40.8K	Hold	603	–	–	0.01%	178
2022 Q3	$75K	Hold	603	–	–	0.02%	168
2022 Q2	$57K	Hold	603	–	–	0.02%	187
2022 Q1	$97K	Buy	603 +224	+59%	+$43.6K	0.03%	197
2021 Q4	$126K	Hold	379	–	–	0.03%	203
2021 Q3	$176K	Buy	+379	New	+$184K	0.06%	178

Other funds holding DNA

Viking Global Investors

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return

Legal & General Group

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return

Two Sigma Advisers

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return